Current Atherosclerosis Reports

Papers
(The TQCC of Current Atherosclerosis Reports is 14. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)
ArticleCitations
Revascularization Options for Left Main Disease: What Clinicians Need to Know157
Highlights of Cardiovascular Disease Prevention Studies Presented at the 2024 American Heart Association Scientific Sessions144
Polysocial Risk Scores: Implications for Cardiovascular Disease Risk Assessment and Management115
The Expanding Scope of GLP-1 Receptor Agonists: Six Uses Beyond Diabetes113
Whether and Why Do We Need a Vaccine Against Atherosclerosis? Can We Expect It Anytime Soon?99
The Greatly Under-Represented Role of Smooth Muscle Cells in Atherosclerosis79
A Narrative Review of the Association Between Depression and Heart Disease Among Women: Prevalence, Mechanisms of Action, and Treatment78
PCSK9 Inhibition and Risk of Diabetes: Should We Worry?67
The Effects of FABP4 on Cardiovascular Disease in the Aging Population67
Anti-apoC-III Therapies and Implications for Treatment of Pancreatitis and Cardiovascular Disease66
The Role of the PI3K/Akt/mTOR Pathway in Atherosclerosis: Mechanisms, Therapeutic Potential, and Emerging Targeted Treatments65
Salutary Effects of Nutritional Ketosis for the Diseased Human Heart57
Polypharmacy and Cardiovascular Diseases: Consideration for Older Adults and Women56
From ‘Omics to Multi-omics Technologies: the Discovery of Novel Causal Mediators51
Genetic Testing for Familial Hypercholesterolemia in Clinical Practice51
Expanding Biology of PCSK9: Roles in Atherosclerosis and Beyond43
Effects of Pioglitazone On Lipoprotein(a): A Meta-analysis43
Spontaneous Coronary Artery Dissection (SCAD): Unveiling the Enigma of the Unexpected Coronary Event41
The Intersection Between COVID-19, Cardiovascular Disease, and Diet: a Review41
Programmable Genome-Editing Technologies as Single-Course Therapeutics for Atherosclerotic Cardiovascular Disease38
Nutrition Interventions for Youth with Dyslipidemia: Who, What, When, and Where?38
Inflammation in the Peri-ACS Period: Ready for Prime Time?37
The Emerging Specialty of Cardio-Rheumatology36
GLP-1 Receptor Agonists and Cardiovascular Disease: What Do Clinicians Need to Know?35
Percutaneous Coronary Interventions in Women35
The Role of Non-Statin Lipid Lowering Therapies to Reduce ASCVD Events in Primary Prevention34
Lipoprotein(a): from Causality to Treatment32
Lipid Lowering Therapy Utilization and Lipid Goal Attainment in Women31
Recent Advances and Perspectives of Metabolomics-Based Investigations in Coronary Heart Disease31
Myeloid Cells in Abdominal Aortic Aneurysm30
ApoC-III as Therapeutic Target: Is it Primetime for Clinical Use?30
The Role of Sleep in Cardiovascular Disease29
Low LDL-C: Is It all Good News?29
Predicting Risk of Cardiovascular Disease EVENTs (PREVENT) Equations: What Clinicians Need to Know?28
Importance of Nutrition Security to CVD Prevention Efforts in the USA28
The Role of Bacterial Extracellular Membrane Nanovesicles in Atherosclerosis: Unraveling a Potential Trigger27
In-Hospital Use of PCSK9 Inhibitors in the Post ACS Patient: What Does the Evidence Show?27
Implementing Reporting Standards for Polygenic Risk Scores for Atherosclerotic Cardiovascular Disease26
Role of RNA-binding Proteins in Regulating Cell Adhesion and Progression of the Atherosclerotic Plaque and Plaque Erosion26
Can Clinical Biomarkers Guide Optimal Therapeutic Selection in Type 2 Diabetes Mellitus? A Scoping Review25
Novel Therapies for Lipoprotein(a): Update in Cardiovascular Risk Estimation and Treatment24
Stress, Vascular Smooth Muscle Cell Phenotype and Atherosclerosis: Novel Insight into Smooth Muscle Cell Phenotypic Transition in Atherosclerosis24
Effects of Omega-3 Fatty Acids on Flow-mediated Dilatation and Carotid Intima Media Thickness: A Meta-analysis24
Exploring the Role of SPARC in Atherosclerosis: Mechanisms and Potential Implications23
Transgender Cardiovascular Health: Practical Management for the Clinician23
Coronary Microvascular Dysfunction: What Clinicians and Investigators Should Know23
Transforming Population Health Screening for Atherosclerotic Cardiovascular Disease with AI-Enhanced ECG Analytics: Opportunities and Challenges22
Do Triglyceride-Rich Lipoproteins Equal Low-Density Lipoproteins in Risk of ASCVD?22
Recent Advances in Stent Technology: Do They Reduce Cardiovascular Events?22
Eliminating Health Disparities in Atrial Fibrillation, Heart Failure, and Dyslipidemia: A Path Toward Achieving Pharmacoequity22
Factors Affecting Circulating Phytosterol Levels: Toward an Integrated Understanding of Atherogenicity and Atheroprotection by Dietary and Circulating Phytosterols21
Highlights of Cardiovascular Disease Prevention Studies Presented at the 2024 American College of Cardiology Conference21
Is Family History for the Management of Cardiovascular Health in Youth Still Relevant in Clinical Practice?20
Membrane Cholesterol Interactions with Proteins in Hypercholesterolemia-Induced Endothelial Dysfunction20
Brief Review: Racial and Ethnic Disparities in Cardiovascular Care with a Focus on Congenital Heart Disease and Precision Medicine19
Highlights of Cardiovascular Disease Prevention Studies Presented at the 2025 European Society of Cardiology Conference19
Cardiovascular Disease in the Middle East and North Africa, 1990–2021: Burden, Trends, and Risk Factors19
Noninvasive Atherosclerotic Phenotyping: The Next Frontier into Understanding the Pathobiology of Coronary Artery Disease19
Clinical Management of Dyslipidemia in Infants and Toddlers19
Is There a Role for Imaging Youth at Risk of Atherosclerosis?19
Cardiovascular Health and Disease in the Pakistani American Population18
Expanding Clinical Indications for Cardiac CT: A Review of Its Current Utility in American and European Guidelines18
Major Concepts in Treatment with Bempedoic Acid and Inclisiran that Clinicians Need To Know18
Gene Regulatory Networks in Coronary Artery Disease18
HIV and Cardiovascular Disease Burden in Young Adults (18–25 years): A Review of Current Evidence18
Statin Use in Special Populations for the Prevention of Cardiovascular Disease in Adults18
Targeting the Gut Microbiome to Treat Cardiometabolic Disease17
Highlights of Cardiovascular Disease Prevention Studies Presented at the 2025 American College of Cardiology Conference17
Natural Sirtuin1 Activators and Atherosclerosis: an Overview17
Pharmacotherapy for Coronary Artery Disease and Acute Coronary Syndrome in the Aging Population17
High Density Lipoprotein Particle Composition, Functionality, Deficiency, and Atherosclerotic Cardiovascular Disease Risk: A Review16
Bempedoic Acid: for Whom and When16
What Causes Premature Coronary Artery Disease?16
Biology, Bias, or Both? The Contribution of Sex and Gender to the Disparity in Cardiovascular Outcomes Between Women and Men16
Inclisiran, Reasons for a Novel Agent in a Crowded Therapeutic Field16
Dietary Management of Atherogenic Dyslipidemia15
A Review of Statin Intolerance: a Focus on Statin-Attributed Muscle Symptoms14
Utility of FFRCT in Patients with Chest Pain14
The Role of Lysyl Oxidase in the Pathological Stage of Atherosclerosis: Structural Stabilizer or Disease Driver?14
Serial Coronary CTA for Monitoring Response to Lipid-Lowering Therapy: A Narrative Review14
Non-obstructive Plaque and Treatment of INOCA: More to Be Learned14
Managing Dyslipidemia in Chronic Kidney Disease: Implications for Cardiovascular and Renal Risk14
Correlation Between Oral Bacteria and Atherosclerotic Thrombotic Disease: Advances in Animal Model Studies14
Anti-Inflammatory Lipid Mediators from Polyunsaturated Fatty Acids: Insights into their Role in Atherosclerosis Microenvironments14
Fixed Combination for the Treatment of Dyslipidaemia14
0.1154408454895